Delivery Order SPE2DB24D1201-SPE2DB25FJEDL
- Not listed
- The Defense Logistics Agency awarded a $4,025.37 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Sunosi 150 mg tablets (30-count package). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 5, 2025, and performance executed from the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Sunosi 150 mg tablets (30-count units) at a firm fixed price totaling $1,345.47. This non-set-aside contract is a child order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which carries a ceiling value of $999,999,999.00 and extends through December 2026. The delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Sunosi 150 mg tablets (30-count units) with a contract value of $2,570.36 and a firm fixed price structure. This delivery order, valued at the ceiling amount specified, represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The work is to be performed at the company's corporate office in Conshohocken, Pennsylvania, and the...
- The Defense Logistics Agency awarded a $1,154.87 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Sunosi 150 mg tablets (30-count units). This competitive, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by August 13, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $1,344.45 to AmerisourceBergen Drug Corp for the supply of Sunosi 75 mg tablets (30-count package) on September 9, 2025, with completion targeted for September 10, 2025. This competitively awarded, firm fixed-price delivery order represents a routine pharmaceutical procurement supporting federal medical supply requirements. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a $2,445.76 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Sunosi 150 mg tablets (30-count). This firm fixed-price contract represents a non-set-aside competitive award and is scheduled for completion by September 5, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Sunosi 150 mg tablets (30-count packages) valued at $1,289.19. This firm fixed-price delivery order will be completed by August 19, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The award was not set aside for...
- The Defense Logistics Agency awarded a $1,817.13 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 tablets of Sunosi 150 mg, with an ultimate completion date of August 13, 2025. This non-set-aside contract was competitively awarded and represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be performed at AmerisourceBergen's corporate headquarters in Conshohocken,...
- AmerisourceBergen Drug Corp received a delivery order valued at $4,627.82 from the Defense Logistics Agency (DLA) on July 22, 2025, for the supply of Sunosi 75 mg tablets (30-count units). This firm fixed-price contract, which is non-set-aside and competitively awarded, is scheduled for completion by July 23, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $2,404.99 for 30 tablets of Sunosi 75 mg on August 1, 2025, with an ultimate completion date of August 4, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed price terms and represents a child award under AmerisourceBergen's larger federal contract vehicle. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where...
- SPE2DB24D1201Indefinite Delivery Contract
- SPE2DB24D1201-SPE2DB25FJEDLDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,842.01 to AmerisourceBergen Drug Corp for the supply of Sunosi 150 mg tablets (30-count units) on September 10, 2025, with completion targeted for September 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills this order as a child contract under its existing Indefinite Delivery Contract with DLA Troop Support Medical. This delivery order represents a routine pharmaceutical procurement supporting federal medical supply needs, likely for military or veteran healthcare systems. AmerisourceBergen Drug Corp maintains a substantial $999.999 billion IDC with the Defense Logistics Agency through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply medications, vaccines, and medical supplies across multiple therapeutic domains. The contractor's extensive federal contract portfolio demonstrates its capability to meet competitive procurement requirements and support the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 9/10/25 |